Michael Grövdal

481 total citations
13 papers, 323 citations indexed

About

Michael Grövdal is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Michael Grövdal has authored 13 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Hematology and 4 papers in Genetics. Recurrent topics in Michael Grövdal's work include Acute Myeloid Leukemia Research (9 papers), Epigenetics and DNA Methylation (6 papers) and Histone Deacetylase Inhibitors Research (4 papers). Michael Grövdal is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Epigenetics and DNA Methylation (6 papers) and Histone Deacetylase Inhibitors Research (4 papers). Michael Grövdal collaborates with scholars based in Sweden, Denmark and Norway. Michael Grövdal's co-authors include Eva Hellström‐Lindberg, Mohsen Karimi, Monika Jansson, Sören Lehmann, Hareth Nahi, Stefan Deneberg, Konstanze Döhner, Christer Paul, Verena I. Gaidzik and Anna Porwit and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Haematology.

In The Last Decade

Michael Grövdal

13 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Grövdal Sweden	7	243	225	58	29	28	13	323
Sue Naim United States	5	134 0.6×	233 1.0×	27 0.5×	29 1.0×	37 1.3×	8	299
Giulia Falconi Italy	13	281 1.2×	189 0.8×	124 2.1×	30 1.0×	32 1.1×	28	369
Fengkuan Yu China	7	222 0.9×	104 0.5×	67 1.2×	73 2.5×	13 0.5×	25	265
Kira Behrens Australia	7	161 0.7×	166 0.7×	50 0.9×	27 0.9×	24 0.9×	10	300
Steven Richebourg France	6	218 0.9×	122 0.5×	68 1.2×	32 1.1×	19 0.7×	10	256
Peter Nöllke Germany	10	298 1.2×	190 0.8×	110 1.9×	55 1.9×	16 0.6×	13	365
Friederike Pastore Germany	8	255 1.0×	164 0.7×	131 2.3×	34 1.2×	23 0.8×	12	303
Ina Stolze Germany	4	316 1.3×	201 0.9×	124 2.1×	80 2.8×	33 1.2×	6	392
Mariam Ibáñez Spain	9	182 0.7×	245 1.1×	32 0.6×	46 1.6×	52 1.9×	28	339
Magda Šišková Czechia	10	344 1.4×	123 0.5×	131 2.3×	32 1.1×	16 0.6×	22	395

Countries citing papers authored by Michael Grövdal

Since Specialization

Citations

This map shows the geographic impact of Michael Grövdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Grövdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Grövdal more than expected).

Fields of papers citing papers by Michael Grövdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Grövdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Grövdal. The network helps show where Michael Grövdal may publish in the future.

Co-authorship network of co-authors of Michael Grövdal

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Grövdal. A scholar is included among the top collaborators of Michael Grövdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Grövdal. Michael Grövdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Mellqvist, Ulf‐Henrik, Qian Cai, Laura Hester, et al.. (2023). Epidemiology and clinical outcomes of light‐chain amyloidosis in Sweden: A nationwide population‐based study. European Journal Of Haematology. 111(5). 697–705. 5 indexed citations

Mellqvist, Ulf‐Henrik, Qian Cai, Laura Hester, et al.. (2022). Light-Chain Amyloidosis in Sweden (2011-2019): Incidence, Disease Burden, and Clinical Outcomes in Real-World Patients. Blood. 140(Supplement 1). 5230–5231. 1 indexed citations

Tobiasson, Magnus, Andreas Lennartsson, Shintaro Katayama, et al.. (2017). Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease. Oncotarget. 8(17). 28812–28825. 39 indexed citations

Grövdal, Michael, Hareth Nahi, Gösta Gahrton, et al.. (2015). Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT. Bone Marrow Transplantation. 50(6). 808–812. 30 indexed citations

Tobiasson, Magnus, Andreas Lennartsson, Shota Katayama, et al.. (2015). 135 IN VITRO AZACITIDINE CULTURE INDUCES DNA DEMETHYLATION AND INCREASED MRNA-LEVELS IN PRIMARY MDS PROGENITOR CELLS. Leukemia Research. 39. S69–S69. 1 indexed citations

Tobiasson, Magnus, Mette Skov Holm, Mohsen Karimi, et al.. (2014). Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial. Blood Cancer Journal. 4(3). e189–e189. 44 indexed citations

Tobiasson, Magnus, Ingunn Dybedal, Hege Garelius, et al.. (2011). Evaluation of Azacitidine in Transfusion-Dependent, Epo-Refractory Patients with Lower-Risk Myelodysplastic Syndrome,. Blood. 118(21). 3798–3798. 1 indexed citations

Deneberg, Stefan, Michael Grövdal, Mohsen Karimi, et al.. (2010). Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia. 24(5). 932–941. 101 indexed citations

Grövdal, Michael, Mohsen Karimi, Anni Aggerholm, et al.. (2010). Maintenance treatment with azacytidine for patients with high‐risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy. British Journal of Haematology. 150(3). 293–302. 44 indexed citations

10.

Deneberg, Stefan, Michael Grövdal, Monika Jansson, et al.. (2008). Different Incidence and Implications of DNA Hypermethylation in De Novo AML Compared to High-Risk MDS and AML Following MDS.. Blood. 112(11). 3337–3337. 1 indexed citations

11.

Grövdal, Michael, Anni Aggerholm, Petar Antunović, et al.. (2008). Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy. Blood. 112(11). 223–223. 13 indexed citations

12.

Grövdal, Michael, Anni Aggerholm, Petar Antunović, et al.. (2007). Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.. Blood. 110(11). 818–818. 5 indexed citations

13.

Grövdal, Michael, Anni Aggerholm, Petar Antunović, et al.. (2007). Negative Effect of DNA Hypermethylation on the Outcome of Intensive Chemotherapy in Older Patients with High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia following Myelodysplastic Syndrome. Clinical Cancer Research. 13(23). 7107–7112. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact